Pharmacokinetic Evaluation of Once-Daily Topical 4% Minocycline Foam in Adult and Pediatric Subjects with Moderate-to-Severe Acne in Two Phase 1 Studies. J of Skin. 2018;2(S1):S34. doi:10.25251/skin.2.supp.33